The Sympathetic Nervous System Regulates Sodium Glucose Co-Transporter 1 Expression in the Kidney
Hyperactivation of the sympathetic nervous system (SNS) has been demonstrated in various conditions including obesity, hypertension and type 2 diabetes. Elevated levels of the major neurotransmitter of the SNS, norepinephrine (NE), is a cardinal feature of these conditions. Increased levels of the s...
Main Authors: | Jennifer Matthews, Moira Hibbs, Lakshini Herat, Markus Schlaich, Vance Matthews |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/11/3/819 |
Similar Items
-
The Impact of SGLT2 Inhibitors in the Heart and Kidneys Regardless of Diabetes Status
by: Jennifer Matthews, et al.
Published: (2023-09-01) -
Determining the Role of SGLT2 Inhibition with Dapagliflozin in the Development of Diabetic Retinopathy
by: Lakshini Y. Herat, et al.
Published: (2022-12-01) -
Comparing and Contrasting the Effects of the SGLT Inhibitors Canagliflozin and Empagliflozin on the Progression of Retinopathy
by: Lakshini Y. Herat, et al.
Published: (2023-04-01) -
The Effect of SGLT2 Inhibition on Diabetic Kidney Disease in a Model of Diabetic Retinopathy
by: Jennifer Rose Matthews, et al.
Published: (2022-02-01) -
Comparative study of sodium-dependent glucose co-transporters in kidneys of Ostrich chickens
by: Piret Hussar, et al.
Published: (2022-07-01)